Ensemble Therapeutics

Ensemble develops Ensemblins to treat diseases by addressing drug targets that are currently inaccessible with small molecule drugs.

Launch date

2002

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	CMEA Ventures 180 Degree Capital	N/A	-
May 2004	ARCH Venture Partners Flagship Pioneering Oxford Bioscience Partners	$15.0m	Series A
Nov 2007	ARCH Venture Partners Harris & Harris Group Flagship Pioneering Oxford Bioscience Partners	$15.0m	Series B
Total Funding		$30.0m

Recent News about Ensemble Therapeutics